Literature DB >> 35074770

Family Caregivers' Experiences With Telehealth During COVID-19: Insights From Michigan.

Minakshi Raj1, Bradley Iott2,3, Denise Anthony2, Jodyn Platt4.   

Abstract

Telehealth can benefit older adults during COVID-19. The purpose of this study was to understand benefits and barriers to telemedicine visits for older adults from the perspectives of family caregivers. A cross-sectional, online survey was conducted across the state of Michigan with family caregivers (n = 90) who responded to open- and closed-ended questions. Perceived benefits of telemedicine included access and rapport; barriers included the appropriateness of telemedicine for certain health care needs. Telemedicine is a likely to remain beyond COVID-19 and can facilitate access to and continuity of care. There are barriers, however, that must be addressed, especially among older patients.
© 2022 Annals of Family Medicine, Inc.

Entities:  

Keywords:  COVID-19; aging; caregivers; telemedicine

Mesh:

Year:  2022        PMID: 35074770      PMCID: PMC8786412          DOI: 10.1370/afm.2760

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  3 in total

1.  Virtually Perfect? Telemedicine for Covid-19.

Authors:  Judd E Hollander; Brendan G Carr
Journal:  N Engl J Med       Date:  2020-03-11       Impact factor: 91.245

2.  Meeting the Care Needs of Older Adults Isolated at Home During the COVID-19 Pandemic.

Authors:  Michael A Steinman; Laura Perry; Carla M Perissinotto
Journal:  JAMA Intern Med       Date:  2020-06-01       Impact factor: 21.873

3.  Who Isn't Using Patient Portals And Why? Evidence And Implications From A National Sample Of US Adults.

Authors:  Denise L Anthony; Celeste Campos-Castillo; Paulina S Lim
Journal:  Health Aff (Millwood)       Date:  2018-12       Impact factor: 6.301

  3 in total
  1 in total

1.  The Pandemic's Agenda.

Authors:  Caroline R Richardson
Journal:  Ann Fam Med       Date:  2022 Jan-Feb       Impact factor: 5.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.